![Sophie Hallakou-Bozec](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sophie Hallakou-Bozec is the founder.
She founded Poxel SA in 2009 and held the title of Senior VP-Research & Development Pharmacology.
She also worked as a Principal at Merck KGaA. Dr. Hallakou-Bozec obtained a doctorate degree from Université Paris Diderot-Paris 7.
| Sociétés | Poste | Fin |
|---|---|---|
| MERCK KGAA | Corporate Officer/Principal | - |
| POXEL | Fondateur | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Poxel SA
 Poxel SA Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company, focuses on the development of novel treatments for serious chronic diseases | Health Technology |
Université Paris Diderot-Paris 7
 Université Paris Diderot-Paris 7 Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
